ORCID as entered in ROS

Select Publications
2024, 'Comparison of Post-Therapy 4 and 24-hour 177Lu-PSMA SPECT/CT and Pre-Therapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castrate-Resistant Prostate Cancer', presented at Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), CANADA, Toronto, 08 June 2024 - 11 June 2024, https://jnm.snmjournals.org/content/65/supplement_2/242460
,